Abstract
ObjectiveAnti-tumour necrosis factor (TNF) antibodies are successfully used for treatment of Crohn’s disease. Nevertheless, approximately 40% of patients display failure to anti-TNF therapy. Here, we characterised molecular mechanisms that are...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have